Marshall University

Marshall Digital Scholar
Gastroenterology

School of Medicine

Fall 9-2015

Multiple Intussusceptions Associated with
Polycythemia in an Anabolic Steroid Abuser , A
Case Report and Literature Review
Y. Cavanagh
Nihar Shah MD
Marshall University, shahn@marshall.edu

A. B. Thomas
A. Gupta

Follow this and additional works at: http://mds.marshall.edu/sm_gastro
Part of the Gastroenterology Commons
Recommended Citation
Cavanaugh, Y., Shah, N., Thomas, A.B. and Gupta, A., 2015. Multiple intussusceptions associated with polycythemia in an anabolic
steroid abuser, a case report and literature review. Annals of Medical and Health Sciences Research, 5(5), pp.368-372.

This Article is brought to you for free and open access by the School of Medicine at Marshall Digital Scholar. It has been accepted for inclusion in
Gastroenterology by an authorized administrator of Marshall Digital Scholar. For more information, please contact zhangj@marshall.edu,
martj@marshall.edu.

Case Report

Multiple Intussusceptions Associated with
Polycythemia in an Anabolic Steroid Abuser , A Case
Report and Literature Review
Cavanagh Y, Shah N1,2, Thomas AB, Gupta A1
Department of Medicine, St. Joseph’s Regional Medical Center, Paterson, NJ, USA, 1Department of Gastroenterology,
St. Joseph’s Regional Medical Center, Paterson, NJ, USA, 2Department of Gastroenterology, Seton Hall University,
West Orange, New Jersey, USA
Address for correspondence:
Dr. Yana Cavanagh,
Department of Medicine,
St. Joseph’s Regional Medical Center,
703 Main Street, Paterson, NJ 07503,
USA.
E‑mail: yanacavanagh@gmail.com

Abstract
Intussusceptions are generally associated with mechanical lead points or localized inflammation
that function as foci for intestinal telescoping. We present the case of a patient whose abuse
of anabolic steroids resulted in the development of multiple simultaneous intussusceptions.
Our patient had no additional identifiable risk factors for intussusception. Consistent with
previous reports, corticosteroid induced polycythemia and its consequent hyperviscosity led
to intravascular sludging and mesenteric ischemia with associated bowel wall thickening.
The localized intestinal induration then served as mechanical foci for intussusception. Due
to the illicit nature of anabolic androgenic steroid (AAS) abuse, the physiologic effects of
supraphysiologic doses are sparsely reported and poorly understood. The scope of AAS abuse
and its consequences are likely under‑reported and under‑recognized within the medical
community. Our case presented a unique diagnostic and therapeutic challenge with which
we aim to increasing awareness and clinical suspicion for AAS among healthcare personnel.
Keywords: Anabolic, Steroid, Intussusception, Androgens, Polycythemia, Hormones,
Anabolic androgenic steroid

Introduction
Androgens are hormones that are based on the structure
of testosterone and act on various tissues via androgen
receptors to produce anabolic effects (i.e., Increasing protein
synthesis), as well as androgenic effects, (i.e., Development
of secondary sexual characteristics).[1,2] In addition, they
displace glucocorticoids from their respective receptors,
exerting an anti‑catabolic effect, which also promotes protein
synthesis.[2,3] Androgen receptors are found in bone, adipose
tissue, skeletal muscle, brain, prostate, liver, kidney, and
reproductive tissues, which accounts for both their desired
and adverse effects.[2] Anabolic‑androgenic steroids (AAS) do
possess medical indication, primarily in androgen replacement
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therapies for patients with established androgen deficiencies;[1]
however, AAS are frequently abused by individuals interested
in capitalizing on their effects.
Anabolic‑androgenic steroids use and abuse are important
concerns for the medical community, as their utilization
has been steadily increasing over the past four decades,
with a global lifetime prevalence rate for AAS use of 3.3%;
use by males (6.4%) was significantly higher than that by
females (1.6%).[3,4] Professional athletes are a population
classically associated with AAS utilization due to the potential
for an increase in muscle strength,[1,3,5] as well as fat‑free muscle
mass.[3] However, these benefits do not come without risks.
Some reported adverse effects included virilization in female
users, truncal acne, weight gain, gynecomastia, polycythemia,
congestive cardiac failure and myocardial infarctions,
dyslipidemia, mood alteration, and renal failure.[1,2,6‑9] In
addition, the abuse of AAS has expanded beyond the scope of
professional athletes to include high school students (1–5%),
individuals (i.e., recreational body builders), focused on
physique (13.5%), as well as certain occupations (i.e., police
officers).[3,10]
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Due to the predominantly illicit nature of AAS abuse,
studying side effects and complications of supraphysiologic
doses is inherently difficult. Most clinical studies evaluate
low‑dose AAS for the purposes of hormone replacement,
either due to androgen deficiency in hypogonadal syndromes,
cachexia (i.e., conditions such as human immunodeficiency
virus, chronic obstructive pulmonary disease) or age‑related
declines (i.e., testosterone deficiency), although the last
area remains controversial.[6,7,11‑13] Normal daily endogenous
production of cortisol would equate to about 10–50 mg of
exogenously administered cortisol. Men require higher doses
for physiologic homeostasis. [14,15] However, there are no
specific guidelines on the appropriate dosing of AAS to mimic
or supplement, normal physiologic hormone levels.
Bhasin et al.[5] has conducted one of the few randomized studies
to look at the effects of supraphysiologic doses of AAS. In
their trial, patients received weekly intramuscular doses of
600 mg of testosterone enanthate or placebo for 10 weeks.[5]
However, the doses utilized were still substantially lower than
those commonly utilized by athletes, who additionally tend to
stack multiple AAS preparations in an attempt to increase the
desired effects while decreasing potential adverse effects.[2,16]
Therefore, case reports and retrospective studies have been
the principal contributors in identifying common, as well as
life‑threatening, complications, which may potentially arise
from AAS abuse.[2,3,17]

Figure 1: Transverse plane computer tomography scan of the abdomen
demonstrating a short segment small bowel intussusception without
evidence of obstruction

Case Report
We present the case of a 34‑year‑old male with a past medical
history of hypertension, hypercholesteremia, anxiety, acid reflux,
and irritable bowel syndrome who presented with the complaints
of severe cramping abdominal pain associated with nausea,
vomiting, bright red blood per rectum, and constipation. The
patient denied having similar symptoms in the past or any history
of abdominal surgery. He had an upper gastrointestinal series
10 years ago, which was unremarkable except for a hiatal hernia.
He is a body builder and admitted to the use of AAS. He was
1500 mg of testosterone/nandrolone, via intramuscular injection,
per week for 3 months. 3 weeks prior to the presentation, he
abruptly decreased the dose to 500 mg/week.
On presentation, he was found to be diaphoretic, in mild
distress, with tachycardia at 100 beats/min and tenderness in
the suprapubic region with no guarding, rebound tenderness
or palpable masses. Laboratory studies were normal apart
from an increased white blood cell count at 15.0, increased
hemoglobin at 17.9 and increased hematocrit at 51.2%. He
had mild changes in sodium (134), as well as blood urea
nitrogen (24). He weighed 265 pounds, with a body mass index
of 40.3. A computer tomography (CT) scan of the abdomen
demonstrated mild diffuse nonspecific colonic wall thickening,
with two separate areas of apparent short segment small bowel
intussusception without evidence of obstruction [Figures 1‑4].

Figure 2: Sagittal plane computer tomography scan of the abdomen
demonstrating a short segment small bowel intussusception without
evidence of obstruction

Figure 3: Sagittal plane computer tomography scan of the abdomen
demonstrating a short segment small bowel intussusceptions without
evidence of obstruction
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In addition, a small umbilical hernia containing fat was
visualized. Our patient was subsequently medically managed,
with pain control and hydration. A colonoscopy completed
the day after admission demonstrated edema and erythema
in the distal ileum and colon, most densely starting in the
distal transverse colon and increasing within the rectum.
There were no ulcers, polyps, tumors or sites of hemorrhage
noted. Biopsies were taken from each section of the colon.
The subsequent pathological evaluation indicated acute and
chronic colitis from the descending colon forward and changes
suggesting ischemic colitis in the rectum [Figures 5‑7].

Discussion

A follow‑up CT scan was completed on the third day of admission
but demonstrated no definitive intussusceptions [Figure 8].
There was no longer any overt colitis evidenced though
there may have been an underlying inflammatory process
based on submucosal lucency in the transverse colon. With
the apparent resolution of the small bowel intussusceptions
with conservative medical management, accompanied by a
resolution of the patient’s pain, he was discharged home.

Among other potentially dangerous adverse effects, AAS have
been reported to increase hemoglobin concentrations.[1,7,8,17,18]
This is consistent with our observation, where our patient
was an active AAS user and presented with a significant
increase in hemoglobin concentration. It is of note that
older men (ages 60–74) are at a greater risk of developing
hematocrits above 54%.[6] Coviello et al. [7] investigated the
biochemistry that leads to this effect and have ruled out
increases in erythropoietin levels, as well as expression
of soluble transferrin receptor, the erythropoietin receptor
in the bone marrow[7] as the causative mechanisms.[7] The
current hypothesis is that AAS act by directly stimulating
the bone marrow via a mechanism not yet determined.[7,19]
Interestingly, Verwilghen et al.[8] even suggested that, based
on measurements of peripheral blood, polycythemia seen in
the setting of AAS abuse may be due to a decrease in plasma
volume, demonstrating a compounding relative increase in
hemoglobin concentration.

Figure 4: Transverse plane computer tomography scan of the abdomen
demonstrating a short segment small bowel intussusceptions without
evidence of obstruction, and a small umbilical hernia containing fat

Figure 5: H and E, slide at ×400 magnification showing a few
aggregates of foamy macrophages, superficial erosion, congestion,
and dilatation of lamina propria capillaries, as well as withered crypts

Figure 6: H and E slide at ×400 magnification showing acute and
chronic inflammatory infiltrates

Figure 7: H and E slide at ×400 magnification showing fresh intestinal
hemorrhage
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with previous reports that, the patient’s use of AAS led to
the development of polycythemia.[2,7,9,17,19,24] The consequent
hyperviscosity likely leads to intravascular sludging and
subsequent mesenteric ischemia with associated bowel wall
thickening that subsequently served as a lead points in the
formation of two short segment small bowel intussusceptions.

Figure 8: Resolution of small bowel intussusceptions with no evidence
of overt colitis

Polycythemia inherently places patients at an increased risk
for ischemic events.[B, D, G] Stergiopoulos et al.[17] described
an increase in ischemic cardiac events secondary to the
polycythemia associated with AAS use.[7,17] McCulloch et al.[9]
reported the case of a patient abusing AAS, who presented
with multiple arterial thromboses, including the splenic and
right renal arteries, reporting that the ischemic effects of
steroids can affect larger vessels.[9] Similarly to our case,
Magnusson et al.[20] published a case of polycythemia vera
and associated small bowel obstruction, where laparotomy
demonstrated transmural ischemia in the distal sigmoid
colon and proximal rectum. Plackett et al.[19] also presented
a case of colonic ischemia, with resulting thickening of the
bowel walls that, they also postulated, acted as a lead point
for an intussusception. However, unlike our patient, their
patient presented with colonic ischemia secondary to portal
hypertension. Similarly to our patient, was medically managed
with supportive measures and demonstrated resolution of the
intussusceptions on a repeated CT scan.[19]
Intussusception, although common in children, is a rare
clinical finding in adults. Adults account for only 5% of
all cases of intussusceptions, which are the cause of 1–5%
of all intestinal obstructions in adults.[19,21,22] In adults, it is
generally associated with an underlying mechanical lead
point that serves as a focus for the intussusception (such as
a benign polyp, lipoma, appendix, Meckel diverticulum or
a tumor [i.e., lymphoma]). [23] Additional sources of lead
points can include inflammatory pseudopolyps, arteriovenous
malformations or localized inflammation (due to tuberculosis,
cytomegalovirus, campylobacter, and Crohn’s disease).[19,21‑23]
In the case we are presenting, the patient did not display
any of these typical risk factors for his development of an
intussusception. He had no personal or family history of
polyposis, no intestinal malignancy or isolated infectious
process. The only identified potential causative factor was the
patient’s chronic use of AAS. Our case suggests, consistently

In general, surgical reduction is the preferred treatment
in adults with intussusception.[21,22] This is due to the fact
that intussusception is most commonly associated with a
pathological lesion that leads to a telescoping of the intestine
upon itself by virtue of creating a lead point.[19,21‑23] However, in
our case, as well as that of Plackett et al., the patient’s conditions
resolved with hydration.[19] It remains uncertain whether
decreased plasma volume or a directly mediated stimulation
of the bone marrow are responsible for the hyperviscosity,
which is associated with AAS abuse.[1,6‑8,17] However, in cases
of intussusception secondary to AAS abuse, the physiological
process appears to be amenable to treatment with hydration,
which decreases the degree of hemoconcentration. This could
subsequently spare patients the need for surgical interventions.
In our case, as the patient presented with intussusceptions
without evidence of obstruction, medical management was
justifiably and successfully implemented, even in the setting
of multiple intussusceptions. As such, we propose that a trial of
medical management may be indicated; even in those patients
presenting with mild obstruction secondary to AAS induced
ischemia, due to its unique pathology.
The physiologic process by which AAS induce ischemic events
remains unclear and certainly postulates a field of further
exploration, for follow‑up studies. Currently, polycythemia and
decreased plasma volume appear to mediate hyperviscosity,
causing mechanical vascular obstruction. However, it has
been reported that, androgens potentiate platelet aggregation
via either an increased production of thromboxane A2 or a
decrease in prostaglandin production.[9,24,25] This procoagulant
state further places AAS users at an increased risk for ischemic
events by compounding the hyperviscosity potentiated by
increased hemoglobin concentrations. This direct procoagulant
pathway activation, as suggested by McCulloch, Pilo, and
Johnson et al.’s investigations, as well as other alterations
of the pro and anticoagulant systems, including entities such
as AAS induced vasospasm require further investigation as
contributing factors.[9,24,25]
Our case presented a unique diagnostic, as well as therapeutic
challenge since its presentation as a complication of AAS
abuse, has not been overtly reported in previous literature.
However, as our patient had no identifiable risk factors for
the development of intussusception, the only potential cause
was ischemic colitis secondary to polycythemia, attributable
to our patient’s supraphysiologic AAS use. As it is ethically
dubious to perform clinical trials with supraphysiologic doses
of AAS frequently used by people aiming to capitalize on the
anabolic effects, this case aims to illustrate an additional end
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point complication that can occur secondary to AAS abuse.
Although, we cannot comment on the incidence of similar
complications, clinical awareness, and increased suspicion will
undoubtedly increase the diagnostic margin of this process. As
such, it is important for clinicians to consider intussusception,
as well as other ischemic complications, when treating patients
with a history of AAS abuse.
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